Yifan Pharmaceutical Co., Ltd. (002019.SZ) — Stock Score Summary

Yifan Pharmaceutical Co., Ltd. (002019.SZ) has a MoatMap StockRank of 38/100 based on Quality (52/100), Value (36/100), and Momentum (37/100) factor scores. The current signal is HOLD. Yifan Pharmaceutical lacks a global economic moat and faces severe domestic pricing pressure from China's volume-based procurement (VBP) policy, leading to low and volatile ROIC.

Yifan Pharmaceutical Co., Ltd. develops and manufactures active pharmaceutical ingredients (APIs), generic drugs, and innovative biologics. The company is a global leader in Vitamin B5 production and a pioneer in bringing Chinese-developed biologics to international markets. It operates as a globally integrated pharmaceutical player with a strong pipeline of innovative therapies.

Key Financial Metrics

Price$1.47
Market Cap$1.9B
P/E (TTM)34.59
P/E (Forward)16.44
Price/Book1.37
Return on Equity3.8%
Return on Invested Capital4.9%
Debt/Equity27.11
Gross Margin46.2%
Operating Margin11.8%
Revenue Growth-5.4%
Dividend Yield1.0%
Free Cash Flow$-4M

Yifan Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - General industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Yifan Pharmaceutical Co., Ltd.’s (002019.SZ) StockRank?
MoatMap’s StockRank for Yifan Pharmaceutical Co., Ltd. (002019.SZ) is 38/100, with a Hold signal. It is a composite of Quality (52), Value (36), and Momentum (37) factor ranks across MoatMap’s 19,000+ stock universe.
Does Yifan Pharmaceutical Co., Ltd. have an economic moat?
Yifan Pharmaceutical Co., Ltd. (002019.SZ) has a Quality factor score of 52/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Yifan Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Yifan Pharmaceutical Co., Ltd. (002019.SZ) is Hold, based on a StockRank of 38/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Yifan Pharmaceutical Co., Ltd. in?
Yifan Pharmaceutical Co., Ltd. (002019.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry (China).